US5021456A
(en)
|
1988-02-25 |
1991-06-04 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US4965288A
(en)
|
1988-02-25 |
1990-10-23 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5182297A
(en)
|
1988-02-25 |
1993-01-26 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5059714A
(en)
|
1988-02-25 |
1991-10-22 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5252608A
(en)
|
1988-02-25 |
1993-10-12 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US4943593A
(en)
|
1988-02-25 |
1990-07-24 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5120764A
(en)
|
1988-11-01 |
1992-06-09 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US4997854A
(en)
|
1989-08-25 |
1991-03-05 |
Trustees Of Boston University |
Anti-fibrotic agents and methods for inhibiting the activity of lysyl oxidase in-situ using adjacently positioned diamine analogue substrates
|
US6319494B1
(en)
|
1990-12-14 |
2001-11-20 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
AU712082B2
(en)
|
1996-02-28 |
1999-10-28 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
US6297239B1
(en)
|
1997-10-08 |
2001-10-02 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
JP2001002661A
(ja)
|
1999-06-22 |
2001-01-09 |
Ricoh Co Ltd |
ニトリル化合物及びその製造方法
|
US6465648B1
(en)
|
1999-06-22 |
2002-10-15 |
Ricoh Company, Ltd. |
Reaction product, process of producing same, electrophotographic photoconductor using same, electrophotographic apparatus having the photoconductor, and process cartridge for electrophotographic apparatus
|
US6632815B2
(en)
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
MX228790B
(es)
|
1999-09-17 |
2005-06-30 |
Millennium Pharm Inc |
Inhibidores del factor xa.
|
US20020065303A1
(en)
|
2000-02-01 |
2002-05-30 |
Bing-Yan Zhu |
Bivalent phenylene inhibitors of factor Xa
|
JP2001335476A
(ja)
|
2000-05-29 |
2001-12-04 |
Shionogi & Co Ltd |
三環化合物の新規用途
|
US6599926B2
(en)
|
2000-06-23 |
2003-07-29 |
Bristol-Myers Squibb Company |
Heteroaryl-phenyl substituted factor Xa inhibitors
|
AU2001288617A1
(en)
|
2000-09-05 |
2002-03-22 |
Neogenesis Pharmaceuticals Inc. |
Methods for forming combinatorial libraries combining amide bond formation with epoxide opening
|
WO2002051775A2
(en)
|
2000-12-22 |
2002-07-04 |
Neogenesis Pharmaceuticals, Inc. |
Methods for forming combinatorial libraries using reductive amination
|
DE10104279A1
(de)
|
2001-01-31 |
2002-08-01 |
Heinz Langhals |
Kompetitive Prionen-Reagenzien und ihre Anwendung in Diagnostik und Therapie
|
FR2828206B1
(fr)
|
2001-08-03 |
2004-09-24 |
Centre Nat Rech Scient |
Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
|
EP1426046A4
(en)
|
2001-09-14 |
2005-11-02 |
Shionogi & Co |
NEW USE OF TRICYCLIC COMPOUNDS
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
CN1726189A
(zh)
|
2002-12-11 |
2006-01-25 |
伊莱利利公司 |
新颖的mch受体拮抗剂
|
AU2003300791A1
(en)
|
2002-12-13 |
2004-07-09 |
Neurogen Corporation |
Combination therapy for the treatment of pain
|
JP2006521357A
(ja)
*
|
2003-03-24 |
2006-09-21 |
メルク エンド カムパニー インコーポレーテッド |
ナトリウムチャンネル遮断薬としてのビアリール置換6員複素環化合物
|
US7244763B2
(en)
|
2003-04-17 |
2007-07-17 |
Warner Lambert Company Llc |
Compounds that modulate PPAR activity and methods of preparation
|
WO2005014599A1
(en)
|
2003-06-04 |
2005-02-17 |
Cellular Genomics, Inc. |
Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US7834013B2
(en)
|
2003-11-19 |
2010-11-16 |
Glaxosmithkline Llc |
Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40
|
WO2005086808A2
(en)
|
2004-03-08 |
2005-09-22 |
The University Of North Carolina At Chapel Hill |
NOVEL DICATIONIC IMIDAZO[1,2-a]PYRIDINES AND 5,6,7,8-TETRAHYDRO-IMIDAZO[1,2a]PYRIDINES AS ANTIPROTOZOAL AGENTS
|
JP2007530694A
(ja)
*
|
2004-03-29 |
2007-11-01 |
メルク エンド カムパニー インコーポレーテッド |
ナトリウムチャネル遮断薬としてのビアリール置換ピラジノン
|
JP4859665B2
(ja)
|
2004-03-30 |
2012-01-25 |
武田薬品工業株式会社 |
アルコキシフェニルプロパン酸誘導体
|
PL3153514T3
(pl)
|
2004-05-13 |
2022-01-10 |
Icos Corporation |
Chinazolinony jako inhibitory ludzkiej 3-kinazy fosfatydyloinozytolowej delta
|
US20060019967A1
(en)
|
2004-07-21 |
2006-01-26 |
Su-Ying Wu |
SARS CoV main protease inhibitors
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
US20080021069A1
(en)
|
2004-10-08 |
2008-01-24 |
Takeda Pharmaceutical Company Limited |
Receptor Function Regulating Agent
|
WO2006040646A1
(en)
|
2004-10-14 |
2006-04-20 |
Pfizer, Inc. |
Benzimidazole or indole amides as inhibitors of pin1
|
US20080312277A1
(en)
|
2004-11-03 |
2008-12-18 |
Leonard James N |
Gpr41 and Modulators Thereof for the Treatment of Insulin-Related Disorders
|
CN101106991A
(zh)
|
2005-01-28 |
2008-01-16 |
默克公司 |
抗糖尿病的双环化合物
|
DE602006008576D1
(de)
|
2005-01-31 |
2009-10-01 |
Merck & Co Inc |
Antidiabetische bicyclische verbindungen
|
EP1845988A2
(en)
|
2005-02-11 |
2007-10-24 |
3M Innovative Properties Company |
Substituted imidazoquinolines and imidazonaphthyridines
|
US20090142345A1
(en)
|
2005-03-15 |
2009-06-04 |
Takeda Pharmaceutical Company Limited |
Prophylactic/therapeutic agent for cancer
|
CA2607147C
(en)
|
2005-05-09 |
2018-07-17 |
Ono Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
US7465804B2
(en)
|
2005-05-20 |
2008-12-16 |
Amgen Inc. |
Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
|
JP5252635B2
(ja)
|
2005-07-01 |
2013-07-31 |
メダレックス インコーポレーティッド |
プログラム死リガンド1(pd−l1)に対するヒトモノクローナル抗体
|
EP1916234B1
(en)
|
2005-07-29 |
2014-11-12 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
TW201402124A
(zh)
|
2005-08-19 |
2014-01-16 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
TWI382019B
(zh)
|
2005-08-19 |
2013-01-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之胺基二氮雜呯
|
CA2621949A1
(en)
|
2005-09-14 |
2007-03-22 |
Amgen Inc. |
Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
|
AU2006304400A1
(en)
|
2005-10-19 |
2007-04-26 |
Merck Sharp & Dohme Corp. |
CETP inhibitors
|
WO2007049050A2
(en)
|
2005-10-27 |
2007-05-03 |
Heptahelix Ab |
Modulators of gpr40 for the treatment of diabetes
|
JP4990789B2
(ja)
|
2005-11-04 |
2012-08-01 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
Gpr40とホスホリパーゼとを用いる疾患に有用な物質のスクリーニング方法
|
US20100249175A1
(en)
|
2005-12-02 |
2010-09-30 |
Wilson W David |
Dicationic compounds which selectively recognize G-quadruplex DNA
|
LT1976828T
(lt)
|
2005-12-29 |
2017-04-25 |
Celtaxsys, Inc. |
Diamino dariniai, kaip leukotrieno a4 hidrolazės inhibitoriai
|
EA200801865A1
(ru)
|
2006-02-22 |
2009-02-27 |
Филоджен Спа |
Опухолевые маркеры сосудов
|
JP2009530281A
(ja)
|
2006-03-14 |
2009-08-27 |
アムジエン・インコーポレーテツド |
代謝障害の治療に有用である二環式カルボン酸誘導体
|
DE102006012251A1
(de)
|
2006-03-15 |
2007-11-08 |
Grünenthal GmbH |
Substituierte 4-Amino-chinazolin-Derivate und ihre Verwendung zur Herstellung von Arzneimitteln
|
WO2007109376A2
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Anti-tumor cell antigen antibody therapeutics
|
ATE529405T1
(de)
|
2006-03-31 |
2011-11-15 |
Novartis Ag |
(4-(4-ä6-(trifluoromethyl-pyridin-3-ylamino)-n- enthaltend-heteroarylü-phenyl)-cyclohexyl)- essigsäure-derivate und ihre pharmazeutische anwendungen
|
TW200815377A
(en)
|
2006-04-24 |
2008-04-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
EP1849781A1
(en)
|
2006-04-28 |
2007-10-31 |
Laboratorios del Dr. Esteve S.A. |
Substituted 3-Amino-4-hydroxy pyrrolidines compounds, their preparation and use as medicaments
|
EP2021338A1
(en)
|
2006-05-09 |
2009-02-11 |
Pfizer Products Inc. |
Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
|
MX2008014204A
(es)
|
2006-05-11 |
2008-11-14 |
Sanofi Aventis |
Acidos carboxilicos sustituidos con 4,5-difenil-pirimidinilo, metodo para su produccion y su uso como medicamentos.
|
DE102006021874B4
(de)
|
2006-05-11 |
2008-03-27 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102006021872B4
(de)
|
2006-05-11 |
2008-04-17 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP5271895B2
(ja)
|
2006-05-15 |
2013-08-21 |
メルク・シャープ・アンド・ドーム・コーポレーション |
抗糖尿病性の二環式化合物
|
PE20080993A1
(es)
|
2006-06-27 |
2008-10-06 |
Takeda Pharmaceutical |
Compuestos ciclicos fusionados como moduladores del receptor gpr40
|
US20100056495A1
(en)
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2662305C
(en)
|
2006-09-07 |
2012-04-17 |
Amgen Inc. |
Heterocyclic gpr40 modulators
|
WO2008037266A1
(en)
|
2006-09-25 |
2008-04-03 |
Universite Libre De Bruxelles |
Inhibitors of conventional protein kinase c isozymes and use thereof for treating inflammatory diseases
|
WO2008063768A2
(en)
|
2006-10-12 |
2008-05-29 |
Case Western Reserve University |
Compositions and methods for treating metabolic diseases
|
US8039484B2
(en)
|
2006-10-31 |
2011-10-18 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
WO2008054674A2
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
US7750048B2
(en)
|
2006-11-15 |
2010-07-06 |
Janssen Pharmaceutica Nv |
GPR40 agonists
|
TW200838526A
(en)
|
2006-12-01 |
2008-10-01 |
Astellas Pharma Inc |
Carboxylic acid derivatives
|
WO2008065409A2
(en)
|
2006-12-01 |
2008-06-05 |
Betagenon Ab |
Combination for use in the treatment of cancer, comprising tamoxifen or an aromatase inhibitor
|
EP2099789A4
(en)
|
2006-12-04 |
2012-02-15 |
Boehringer Ingelheim Int |
INHIBITORS OF HIV REPLICATION
|
AU2007333234A1
(en)
|
2006-12-11 |
2008-06-19 |
Novartis Ag |
Method of preventing or treating myocardial ischemia
|
AU2007338792B2
(en)
|
2006-12-20 |
2012-05-31 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
WO2008079965A1
(en)
|
2006-12-22 |
2008-07-03 |
Incyte Corporation |
Substituted heterocycles as janus kinase inhibitors
|
BRPI0722070A2
(pt)
|
2006-12-28 |
2014-04-08 |
Abbott Lab |
Inibidores de poli(adp-ribose)polimerase
|
WO2008090327A1
(en)
|
2007-01-22 |
2008-07-31 |
Betagenon Ab |
New combination for use in the treatment of cancer
|
WO2008090356A1
(en)
|
2007-01-25 |
2008-07-31 |
Betagenon Ab |
Thiazolidinone derivatives useful in the treatment of cancer and disorders caused by excess adiposity
|
WO2008106202A1
(en)
|
2007-02-27 |
2008-09-04 |
Housey Gerard M |
Theramutein modulators
|
KR101737753B1
(ko)
|
2007-03-12 |
2017-05-18 |
와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 |
페닐 아미노 피리미딘 화합물 및 이의 용도
|
US7572934B2
(en)
|
2007-04-16 |
2009-08-11 |
Amgen Inc. |
Substituted biphenyl GPR40 modulators
|
US8318781B2
(en)
|
2007-04-26 |
2012-11-27 |
Japan Science And Technology Agency |
G-protein-conjugated receptor agonist
|
US20090214529A9
(en)
|
2007-05-22 |
2009-08-27 |
Taigen Biotechnology Co., Ltd. |
Kinesin inhibitors
|
WO2008144925A1
(en)
|
2007-05-30 |
2008-12-04 |
Aegera Therapeutics Inc. |
Iap bir domain binding compounds
|
WO2008156656A2
(en)
|
2007-06-13 |
2008-12-24 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Method for making biaryl compounds, compounds made by the method, and method for their use
|
EP2002838A1
(de)
|
2007-06-13 |
2008-12-17 |
Bayer Schering Pharma AG |
Verwendung von Aryl/Hetarylamid-Derivaten als Modulatoren des EP2-Rezeptors
|
CN101784548B
(zh)
|
2007-06-29 |
2013-07-17 |
吉里德科学公司 |
嘌呤衍生物及其作为toll样受体7的调节剂的用途
|
WO2009017822A2
(en)
|
2007-08-02 |
2009-02-05 |
Amgen Inc. |
Pi3 kinase modulators and methods of use
|
HUE025283T2
(en)
|
2007-08-02 |
2016-03-29 |
Gilead Biologics Inc |
LOX and LOX2 inhibitors and their use
|
TWI600639B
(zh)
|
2007-08-17 |
2017-10-01 |
杜邦股份有限公司 |
製備5-鹵烷基-4,5-二氫異唑衍生物之化合物
|
WO2009038204A1
(ja)
|
2007-09-17 |
2009-03-26 |
Pharma Frontier Co., Ltd. |
新規長鎖脂肪酸誘導体化合物及びそれら化合物を有効成分とするgタンパク質共役型レセプター作動剤
|
AU2008303975B2
(en)
|
2007-09-21 |
2013-05-16 |
Sanofi |
(Cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
|
WO2009039943A1
(de)
|
2007-09-21 |
2009-04-02 |
Sanofi-Aventis |
(carboxylalkylen-phenyl)-phenyl-oxalamide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
CN101827832B
(zh)
|
2007-10-08 |
2014-05-07 |
阿德维纳斯治疗私人有限公司 |
作为葡糖激酶活化剂的乙酰胺衍生物、其制备方法及医药应用
|
EP2205548A1
(en)
|
2007-10-10 |
2010-07-14 |
Amgen, Inc |
Substituted biphenyl gpr40 modulators
|
JP2011016722A
(ja)
|
2007-10-23 |
2011-01-27 |
Astellas Pharma Inc |
チアゾリジンジオン化合物
|
CA2703106C
(en)
|
2007-10-24 |
2015-12-01 |
Astellas Pharma Inc. |
Azolecarboxamide derivatives as trka inhibitors
|
KR101565622B1
(ko)
|
2007-10-26 |
2015-11-03 |
니뽄 다바코 산교 가부시키가이샤 |
스피로 고리 화합물 및 이의 의약 용도
|
CA2703217A1
(en)
|
2007-10-29 |
2009-05-07 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8450522B2
(en)
|
2008-03-06 |
2013-05-28 |
Amgen Inc. |
Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
HUE036813T2
(hu)
|
2008-07-08 |
2018-07-30 |
Incyte Holdings Corp |
1,2,5-Oxadiazolok mint indolamin-2,3-dioxigenáz inhibitorok
|
PL2310509T3
(pl)
|
2008-07-21 |
2015-08-31 |
Apogenix Ag |
Jednołańcuchowe cząsteczki TNFSF
|
US8586607B2
(en)
|
2008-07-28 |
2013-11-19 |
Syddansk Universitet |
Compounds for the treatment of metabolic diseases
|
DK2313111T3
(da)
|
2008-08-01 |
2013-12-02 |
Ventirx Pharmaceuticals Inc |
Toll-lignende receptoragonistformuleringer og anvendelse deraf
|
US8652843B2
(en)
|
2008-08-12 |
2014-02-18 |
Oncomed Pharmaceuticals, Inc. |
DDR1-binding agents and methods of use thereof
|
DE102008037790A1
(de)
|
2008-08-14 |
2010-02-18 |
Merck Patent Gmbh |
Bicyclische Triazolderivate
|
US20100130522A1
(en)
|
2008-10-01 |
2010-05-27 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
EP2358656B1
(en)
|
2008-10-15 |
2014-01-01 |
Amgen, Inc |
Spirocyclic gpr40 modulators
|
EA201100921A1
(ru)
|
2008-12-08 |
2011-12-30 |
Эроскрин С.А. |
Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
JP5600116B2
(ja)
|
2008-12-09 |
2014-10-01 |
ギリアード サイエンシーズ, インコーポレイテッド |
Toll様受容体のモジュレーター
|
CN102264737A
(zh)
|
2008-12-23 |
2011-11-30 |
雅培制药有限公司 |
抗病毒化合物
|
MX2011007543A
(es)
|
2009-01-19 |
2011-09-06 |
Daiichi Sankyo Co Ltd |
Compuesto ciclico que contiene heteroatomos.
|
AU2010206789A1
(en)
|
2009-01-23 |
2011-07-28 |
Merck Sharp & Dohme Corp. |
Bridged and fused antidiabetic compounds
|
EP2389369A1
(en)
|
2009-01-23 |
2011-11-30 |
Schering Corporation |
Pentafluorosulpholane-containing antidiabetic compounds
|
EP2389226B1
(en)
|
2009-01-23 |
2013-11-20 |
Merck Sharp & Dohme Corp. |
Bridged and fused heterocyclic antidiabetic compounds
|
TW201040186A
(en)
|
2009-02-05 |
2010-11-16 |
Schering Corp |
Phthalazine-containing antidiabetic compounds
|
WO2010091413A1
(en)
|
2009-02-09 |
2010-08-12 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
BRPI1007836A2
(pt)
|
2009-02-27 |
2015-09-01 |
Enanta Phamaceuticals Inc |
Inibidores do vírus c da hepatite
|
WO2010111534A1
(en)
|
2009-03-27 |
2010-09-30 |
Presidio Pharmaceuticals, Inc. |
Fused ring inhibitors of hepatitis c
|
WO2010123016A1
(ja)
|
2009-04-22 |
2010-10-28 |
アステラス製薬株式会社 |
カルボン酸化合物
|
JP2012136438A
(ja)
|
2009-04-22 |
2012-07-19 |
Astellas Pharma Inc |
テトラゾール化合物
|
TW202042807A
(zh)
|
2009-05-13 |
2020-12-01 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物
|
WO2010143733A1
(en)
|
2009-06-09 |
2010-12-16 |
Takeda Pharmaceutical Company Limited |
Novel fused cyclic compound and use thereof
|
CN103819459B
(zh)
|
2009-06-11 |
2017-05-17 |
艾伯维巴哈马有限公司 |
抗病毒化合物
|
TWI491606B
(zh)
|
2009-07-13 |
2015-07-11 |
Gilead Sciences Inc |
調節細胞凋亡信號之激酶的抑制劑
|
HUE031797T2
(en)
|
2009-08-18 |
2017-08-28 |
Ventirx Pharmaceuticals Inc |
Substituted benzoazepines as Toll-like receptor modulators
|
CN105669553A
(zh)
|
2009-08-18 |
2016-06-15 |
文蒂雷克斯药品公司 |
作为toll样受体调节剂的取代的苯并氮杂*
|
GB0914856D0
(en)
|
2009-08-25 |
2009-09-30 |
Ark Therapeutics Ltd |
Compounds
|
EP2475254A4
(en)
|
2009-09-11 |
2013-05-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
EP2477987B1
(en)
|
2009-09-14 |
2018-01-10 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors
|
BR112012007979A2
(pt)
|
2009-10-06 |
2016-03-29 |
Bristol Myers Squibb Co |
moduladores de gpr40 de pirrolidina
|
AR078522A1
(es)
|
2009-10-15 |
2011-11-16 |
Lilly Co Eli |
Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
|
AU2010310813B2
(en)
|
2009-10-22 |
2015-06-18 |
Gilead Sciences, Inc. |
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
|
WO2011052756A1
(ja)
|
2009-10-30 |
2011-05-05 |
持田製薬株式会社 |
新規3-ヒドロキシ-5-アリールイソキサゾール誘導体
|
WO2011057214A2
(en)
|
2009-11-09 |
2011-05-12 |
Neurogenetic Pharmaceuticals, Inc. |
Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
|
CA2782024A1
(en)
|
2009-11-25 |
2011-06-03 |
Schering Corporation |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
AR078948A1
(es)
|
2009-11-30 |
2011-12-14 |
Lilly Co Eli |
Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes
|
PL2513053T3
(pl)
|
2009-12-18 |
2018-03-30 |
Ogeda Sa |
Pochodne kwasu pirolidyno-karboksylowego jako agoniści receptora 43 sprzężonego z białkiem G (GPR43), kompozycja farmaceutyczna i sposoby do zastosowania w leczeniu zaburzeń metabolicznych
|
WO2011076734A1
(en)
|
2009-12-21 |
2011-06-30 |
Euroscreen S.A. |
Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
|
WO2011076732A1
(en)
|
2009-12-21 |
2011-06-30 |
Euroscreen S.A. |
Compounds, pharmaceutical composition and methods for use in treating gastrointestinal disorders
|
MX2012007474A
(es)
|
2009-12-25 |
2012-08-01 |
Mochida Pharm Co Ltd |
Derivados de 3-hidroxi-5-arilisotiazol novedosos.
|
WO2011080755A1
(en)
|
2009-12-29 |
2011-07-07 |
Advinus Therapeutics Private Limited |
Fused nitrogen heterocyclic compounds, process of preparation and uses thereof
|
WO2011082400A2
(en)
*
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
WO2011092284A1
(en)
|
2010-01-29 |
2011-08-04 |
Euroscreen S.A. |
Novel amino acid derivatives and their use as gpr43 receptor modulators
|
KR20130008021A
(ko)
|
2010-02-04 |
2013-01-21 |
길리아드 바이오로직스, 인크. |
리실 산화효소-유사 2 (loxl2)에 결합하는 항체, 및 그를 위한 사용 방법
|
US9186337B2
(en)
|
2010-02-24 |
2015-11-17 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae
|
AU2011232348A1
(en)
|
2010-03-24 |
2012-10-11 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of Flavivirus infections
|
EP2550262A1
(en)
|
2010-03-24 |
2013-01-30 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
MA34097B1
(fr)
|
2010-03-30 |
2013-03-05 |
Novartis Ag |
Utilisations d'inhibiteurs de dgat1
|
US8686048B2
(en)
|
2010-05-06 |
2014-04-01 |
Rhizen Pharmaceuticals Sa |
Immunomodulator and anti-inflammatory compounds
|
MX2012013031A
(es)
|
2010-05-12 |
2012-12-17 |
Univ Vanderbilt |
Potenciadores alostericos mglur4 de sulfona heterociclica, composiciones y metodos para tratar disfuncion neurologica.
|
BR112012028707A2
(pt)
|
2010-05-13 |
2019-09-24 |
Univ Indiana Res & Tech Corp |
composto de glucagon da superfamília de peptídeos exibindo atividade do receptor g com proteína acoplada, pró farmaco, dímero ou multímro, composição farmacêutica que o compreendem e método de administração do mesmo.
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
EP2578585B1
(en)
|
2010-05-31 |
2016-07-20 |
ONO Pharmaceutical Co., Ltd. |
Purinone derivative as btk kinase inhibitor
|
WO2011151436A2
(en)
|
2010-06-04 |
2011-12-08 |
Euroscreen S.A. |
Novel compounds, method for use them and pharmaceutical composition containing them
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
JP2012036168A
(ja)
|
2010-07-15 |
2012-02-23 |
Daiichi Sankyo Co Ltd |
ヘテロ原子を有する環状化合物を含有する医薬組成物
|
JP5917511B2
(ja)
|
2010-07-20 |
2016-05-18 |
カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチCouncil Of Scientific & Industrial Research |
規則性メソポーラスチタノケイ酸塩およびその調製のための方法
|
EP2595613B1
(en)
|
2010-07-22 |
2019-01-09 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Compounds for use in a method of preventing or treating viral infection
|
PT2608809T
(pt)
|
2010-08-27 |
2019-08-26 |
Gilead Biologics Inc |
Anticorpos para a metaloproteinase 9 da matriz
|
WO2012036168A1
(ja)
|
2010-09-14 |
2012-03-22 |
北海道公立大学法人札幌医科大学 |
筋ジストロフィーを処置するための組成物
|
WO2012050918A2
(en)
|
2010-09-29 |
2012-04-19 |
Presidio Pharmaceutical, Inc. |
Tricyclic fused ring inhibitors of hepatitis c
|
CN103237549A
(zh)
|
2010-10-01 |
2013-08-07 |
帆德制药股份有限公司 |
过敏性疾病的治疗方法
|
WO2012045090A2
(en)
|
2010-10-01 |
2012-04-05 |
Ventirx Pharmaceuticals, Inc. |
Therapeutic use of a tlr agonist and combination therapy
|
AU2011313191A1
(en)
|
2010-10-08 |
2013-05-02 |
Mochida Pharmaceutical Co., Ltd. |
Cyclic amide derivative
|
EP2640701B1
(en)
|
2010-11-15 |
2017-07-05 |
Bayer Intellectual Property GmbH |
Cyanoenamines and their use as fungicides
|
CA2817840A1
(en)
|
2010-11-17 |
2012-05-24 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US20130310379A1
(en)
|
2010-11-19 |
2013-11-21 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
UY33758A
(es)
|
2010-12-01 |
2012-06-29 |
Boehringer Ingelheim Int |
Acidos indaniloxidihidrobenzofuranilaceticos
|
WO2012078802A1
(en)
|
2010-12-08 |
2012-06-14 |
Takeda Pharmaceutical Company Limited |
PREPARATION OF SUBSTITUTED-4,5-DIHYDROPYRROLO[4,3,2-de][2,6]NAPHTHYRIDIN-3(1H)-ONES
|
JP5947311B2
(ja)
|
2010-12-09 |
2016-07-06 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
癌を治療するためのキメラ抗原受容体改変t細胞の使用
|
UY33775A
(es)
|
2010-12-10 |
2012-07-31 |
Gilead Sciences Inc |
Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos
|
WO2012083043A1
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
WO2012083061A2
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
US20150232455A1
(en)
|
2010-12-15 |
2015-08-20 |
Allan C. Krueger |
Anti-viral compounds
|
EP2651920A4
(en)
|
2010-12-15 |
2014-12-17 |
Abbvie Inc |
ANTI-VIRAL COMPOUNDS
|
EP2651926A4
(en)
|
2010-12-15 |
2014-07-09 |
Abbvie Inc |
ANTI-VIRAL COMPOUNDS
|
WO2012088438A1
(en)
|
2010-12-22 |
2012-06-28 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
MX348935B
(es)
|
2011-01-12 |
2017-07-03 |
Ventirx Pharmaceuticals Inc |
Benzoazepinas sustituidas como moduladores de receptores tipo toll.
|
PT2663550T
(pt)
|
2011-01-12 |
2017-03-22 |
Array Biopharma Inc |
Benzoazepinas substítuidas utilizáveis como moduladores dos recetores tipo toll
|
EP2665704A1
(en)
|
2011-01-19 |
2013-11-27 |
Galapagos NV |
Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
|
US8691184B2
(en)
|
2011-01-25 |
2014-04-08 |
The Regents Of The University Of Michigan |
Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
|
ES2732311T3
(es)
|
2011-02-07 |
2019-11-21 |
Univ Washington |
Compuestos de manósidos y procedimientos de uso de los mismos
|
PE20140844A1
(es)
|
2011-02-12 |
2014-07-14 |
Globeimmune Inc |
Terapeuticos a base de levadura para infeccion de la hepatitis b cronica
|
AR085252A1
(es)
|
2011-02-17 |
2013-09-18 |
Takeda Pharmaceutical |
Metodo de produccion de derivado de dihidrobenzofurano opticamente activo
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
ES2887303T3
(es)
|
2011-04-08 |
2021-12-22 |
Janssen Sciences Ireland Unlimited Co |
Derivados de pirimidina para el tratamiento de infecciones víricas
|
JP6054368B2
(ja)
|
2011-04-08 |
2016-12-27 |
カルダン セラピューティクス リミテッドCaldan Therapeutics Limited |
代謝性疾患治療用o−フルオロ置換化合物またはその塩
|
AR085990A1
(es)
|
2011-04-27 |
2013-11-13 |
Mochida Pharm Co Ltd |
Derivados de 1-oxido de 3-hidroxiisotiazol utiles en el tratamiento de la diabetes y composiciones farmaceuticas que los contienen
|
WO2012154608A1
(en)
|
2011-05-06 |
2012-11-15 |
Intellikine, Llc |
Reactive mtor and pi3 kinase inhibitors and uses thereof
|
JP5659189B2
(ja)
|
2011-05-13 |
2015-01-28 |
富士フイルム株式会社 |
非共鳴2光子吸収材料、非共鳴2光子吸収記録材料、記録媒体、記録再生方法及び非共鳴2光子吸収化合物
|
DK2709989T3
(en)
|
2011-05-18 |
2018-04-09 |
Janssen Sciences Ireland Uc |
QUINAZOLINE DERIVATIVES FOR TREATING VIRUS INFECTIONS AND ADDITIONAL DISEASES
|
TWI567061B
(zh)
|
2011-07-01 |
2017-01-21 |
吉李德科學股份有限公司 |
用於治療成癮之化合物
|
WO2013009259A1
(en)
|
2011-07-14 |
2013-01-17 |
Biochromix Pharma Ab |
Novel compounds and their use in therapy
|
AR087451A1
(es)
|
2011-08-17 |
2014-03-26 |
Lilly Co Eli |
Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes
|
JP6101205B2
(ja)
|
2011-08-23 |
2017-03-22 |
中外製薬株式会社 |
抗腫瘍活性を有する新規な抗ddr1抗体
|
GB201115529D0
(en)
|
2011-09-08 |
2011-10-26 |
Imp Innovations Ltd |
Antibodies, uses and methods
|
WO2013052699A2
(en)
|
2011-10-04 |
2013-04-11 |
Gilead Calistoga Llc |
Novel quinoxaline inhibitors of pi3k
|
WO2013057743A1
(en)
|
2011-10-21 |
2013-04-25 |
Connexios Life Sciences Pvt. Ltd |
Process for the preparation of an aryl oxime and salts thereof
|
DK2786996T3
(en)
|
2011-11-29 |
2016-12-19 |
Ono Pharmaceutical Co |
Hydrochloride PURINONDERIVAT
|
MX359634B
(es)
|
2011-12-21 |
2018-10-03 |
Novira Therapeutics Inc |
Agentes antivirales contra la hepatitis b.
|
EP2800736A1
(en)
|
2012-01-04 |
2014-11-12 |
Sanofi |
3-[4-(phenylaminooxalylamino)phenyl]hex-4-ynoic acids, process for preparation thereof and use thereof as a medicament
|
CN103429581B
(zh)
|
2012-01-12 |
2015-08-26 |
江苏恒瑞医药股份有限公司 |
多环类衍生物、其制备方法及其在医药上的应用
|
US9326973B2
(en)
|
2012-01-13 |
2016-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US9403839B2
(en)
|
2012-01-16 |
2016-08-02 |
Vertex Pharmaceuticals Incorporated |
Pyran-spirocyclic piperidine amides as modulators of ion channels
|
UY34573A
(es)
|
2012-01-27 |
2013-06-28 |
Gilead Sciences Inc |
Inhibidor de la quinasa que regula la señal de la apoptosis
|
WO2013116562A1
(en)
|
2012-02-03 |
2013-08-08 |
Gilead Calistoga Llc |
Compositions and methods of treating a disease with (s)-4 amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile
|
KR102064807B1
(ko)
|
2012-02-08 |
2020-01-10 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염을 치료하기 위한 피페리디노-피리미딘 유도체
|
EP2816032A4
(en)
|
2012-02-13 |
2015-09-30 |
Takeda Pharmaceutical |
AROMATIC CORE COMPOUND
|
WO2013122028A1
(ja)
|
2012-02-13 |
2013-08-22 |
武田薬品工業株式会社 |
芳香環化合物
|
WO2013128378A1
(en)
|
2012-02-28 |
2013-09-06 |
Piramal Enterprises Limited |
Phenyl alkanoic acid derivatives as gpr agonists
|
US8642585B2
(en)
|
2012-03-26 |
2014-02-04 |
Boehringer Ingelheim International Gmbh |
Indanyloxydihydrobenzofuranylacetic acids
|
WO2013144129A1
(en)
|
2012-03-31 |
2013-10-03 |
F. Hoffmann-La Roche Ag |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
WO2013154163A1
(ja)
|
2012-04-11 |
2013-10-17 |
持田製薬株式会社 |
新規5-アリール-1,2-チアジナン誘導体
|
US8809376B2
(en)
|
2012-04-30 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
Indanyloxydihydrobenzofuranylacetic acids
|
CN104684906B
(zh)
|
2012-05-11 |
2017-06-09 |
艾伯维公司 |
Nampt抑制剂
|
JP2015520752A
(ja)
|
2012-05-11 |
2015-07-23 |
アッヴィ・インコーポレイテッド |
Nampt阻害薬としてのピリダジンおよびピリジン誘導体
|
US8633182B2
(en)
|
2012-05-30 |
2014-01-21 |
Boehringer Ingelheim International Gmbh |
Indanyloxyphenylcyclopropanecarboxylic acids
|
US9145441B2
(en)
|
2012-06-08 |
2015-09-29 |
Gilead Sciences, Inc. |
Macrocyclic inhibitors of flaviviridae viruses
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
NZ724616A
(en)
|
2012-06-08 |
2018-06-29 |
Gilead Sciences Inc |
Macrocyclic inhibitors of flaviviridae viruses
|
WO2014014530A1
(en)
|
2012-07-17 |
2014-01-23 |
Mylari Banavara L |
Ursolic acid salts for treating diabetes and obesity
|
JP2015127299A
(ja)
|
2012-07-19 |
2015-07-09 |
武田薬品工業株式会社 |
固形製剤
|
WO2014019186A1
(en)
|
2012-08-02 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
WO2014023813A1
(en)
|
2012-08-10 |
2014-02-13 |
Janssen R&D Ireland |
Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
|
CA2882743C
(en)
|
2012-08-27 |
2021-11-30 |
Allergan, Inc. |
Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
|
JOP20130256B1
(ar)
|
2012-08-28 |
2021-08-17 |
Janssenٍ Sciences Ireland Uc |
مركبات سلفامويل اريل اميدات واستعمالها كمواد علاجية لمعالجة التهاب الكبد نوع بي
|
EA026957B1
(ru)
|
2012-08-28 |
2017-06-30 |
Янссен Сайенсиз Айрлэнд Юси |
Конденсированные бициклические производные сульфамоила и их применение в качестве лекарственных препаратов для лечения гепатита b
|
PE20150776A1
(es)
|
2012-09-10 |
2015-05-21 |
Hoffmann La Roche |
6-aminoacido-heteroarildihidropirimidinas para el tratamiento y profilaxis de la infeccion del virus de la hepatitis b
|
US20140073631A1
(en)
|
2012-09-12 |
2014-03-13 |
Vymed Corporation |
Antiviral and antimicrobial compounds
|
TW201427995A
(zh)
|
2012-09-24 |
2014-07-16 |
Gilead Sciences Inc |
抗ddr1抗體
|
JP6530313B2
(ja)
|
2012-10-02 |
2019-06-12 |
エピセラピューティクス アーペーエス |
ヒストン脱メチル化酵素の阻害剤
|
LT2906563T
(lt)
|
2012-10-10 |
2018-06-11 |
Janssen Sciences Ireland Uc |
Pirolo[3,2-d]pirimidino dariniai virusinių infekcijų ir kitų ligų gydymui
|
EP2911669B1
(en)
*
|
2012-10-26 |
2024-04-10 |
The University of Chicago |
Synergistic combination of immunologic inhibitors for the treatment of cancer
|
US20140128333A1
(en)
|
2012-11-02 |
2014-05-08 |
Maqui New Life S.A. |
Compounds, Compositions, and Methods for Decreasing Intestinal Glucose Uptake and Inducing Incretin Release
|
TWI692469B
(zh)
|
2012-11-09 |
2020-05-01 |
南韓商Lg化學股份有限公司 |
Gpr40受體促效劑,製造該促效劑的方法以及含有該促效劑作爲活性劑的醫藥組成物
|
KR101268466B1
(ko)
|
2012-11-12 |
2013-06-04 |
유병수 |
사축형 윈드 터빈
|
SG11201503562PA
(en)
|
2012-11-16 |
2015-06-29 |
Bristol Myers Squibb Co |
Dihydropyrazole gpr40 modulators
|
HUE032401T2
(en)
|
2012-11-16 |
2017-09-28 |
Bristol Myers Squibb Co |
Dihydropyrazole GPR40 modulators
|
MX361585B
(es)
|
2012-11-16 |
2018-12-11 |
Janssen Sciences Ireland Uc |
Derivados 2-aminoquinazolínicos sustituidos heterocíclicos para el tratamiento de infecciones víricas.
|
SG11201503559TA
(en)
|
2012-11-16 |
2015-06-29 |
Bristol Myers Squibb Co |
Pyrrolidine gpr40 modulators
|
AU2013348167A1
(en)
|
2012-11-20 |
2015-05-28 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase
|
AU2013351377A1
(en)
|
2012-11-28 |
2015-04-16 |
Boehringer Ingelheim International Gmbh |
New indanyloxydihydrobenzofuranylacetic acids
|
ES2834959T3
(es)
|
2012-12-06 |
2021-06-21 |
Celgene Quanticel Res Inc |
Inhibidores de histona desmetilasa
|
WO2014086712A1
(en)
|
2012-12-07 |
2014-06-12 |
Boehringer Ingelheim International Gmbh |
New indanyloxydihydrobenzofuranylacetic acids
|
JP6256772B2
(ja)
|
2012-12-19 |
2018-01-10 |
セルジーン クオンティセル リサーチ,インク. |
ヒストンデメチラーゼ阻害剤
|
WO2014100818A1
(en)
|
2012-12-21 |
2014-06-26 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
US9029384B2
(en)
|
2012-12-21 |
2015-05-12 |
Gilead Calistoga, LLC. |
Phosphatidylinositol 3-kinase inhibitors
|
AU2013364068B2
(en)
|
2012-12-21 |
2016-10-20 |
Gilead Calistoga Llc |
Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors
|
JP6314335B2
(ja)
|
2013-02-06 |
2018-04-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新しいインダニルオキシジヒドロベンゾフラニル酢酸
|
CN105189468B
(zh)
|
2013-02-21 |
2018-10-30 |
爱尔兰詹森科学公司 |
用于治疗病毒性感染的2-氨基嘧啶衍生物
|
CA2898482A1
(en)
|
2013-02-22 |
2014-08-28 |
Linda L. Brockunier |
Antidiabetic bicyclic compounds
|
EA030451B1
(ru)
|
2013-02-27 |
2018-08-31 |
Эпитерапьютикс Апс |
Ингибиторы гистондеметилаз
|
US9642843B2
(en)
|
2013-02-27 |
2017-05-09 |
The Regents Of The University Of Michigan |
Pharmaceutical compounds and use of same in cancer and tauopathies
|
HUE034820T2
(en)
|
2013-02-28 |
2018-02-28 |
Janssen Sciences Ireland Uc |
Sulphamoyl arylamides and their use as medicaments for the treatment of hepatitis B
|
CN105209448B
(zh)
|
2013-02-28 |
2018-09-14 |
株式会社蒂奥姆生物 |
三环化合物及其用途
|
WO2014165128A2
(en)
|
2013-03-12 |
2014-10-09 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
EP2968282B1
(en)
|
2013-03-12 |
2018-05-09 |
Celgene Quanticel Research, Inc. |
Histone dementhylase inhibitors
|
KR20150130491A
(ko)
|
2013-03-13 |
2015-11-23 |
제넨테크, 인크. |
피라졸로 화합물 및 그것의 용도
|
JP6276378B2
(ja)
|
2013-03-14 |
2018-02-07 |
セルジーン クオンティセル リサーチ,インク. |
ヒストンデメチラーゼ阻害剤
|
AU2014235280B2
(en)
|
2013-03-15 |
2017-08-31 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
US9763905B2
(en)
|
2013-03-15 |
2017-09-19 |
The Children's Medical Center Corporation |
Therapeutic target for the treatment of cancers and related therapies and methods
|
CN104059039B
(zh)
|
2013-03-22 |
2017-03-15 |
正大天晴药业集团股份有限公司 |
具有gpr40受体功能调节作用的稠环化合物
|
DK2981536T3
(en)
|
2013-04-03 |
2017-09-25 |
Janssen Sciences Ireland Uc |
N-PHENYLC CARBOXAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
|
CN104109115B
(zh)
|
2013-04-16 |
2016-11-23 |
中国科学院上海药物研究所 |
一种含氮杂环链接的苯丙酸类化合物、其药物组合物、制备方法和用途
|
AR096041A1
(es)
|
2013-04-17 |
2015-12-02 |
Piramal Entpr Ltd |
Derivados de ácido carboxílico alquilo sustituidos como agonistas rpg
|
KR101569522B1
(ko)
|
2013-04-18 |
2015-11-17 |
현대약품 주식회사 |
신규한 3-(4-(벤질옥시)페닐)헥스-4-이노익 산 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 약학적 조성물
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
AU2014267198A1
(en)
|
2013-05-17 |
2015-11-05 |
F. Hoffmann-La Roche Ag |
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection
|
SI2997019T1
(sl)
|
2013-05-17 |
2018-12-31 |
Janssen Sciences Ireland Uc, |
Derivati sulfamoiliofenamida in njihova uporaba kot zdravila za zdravljenje hepatitisa B
|
CN104870429B
(zh)
|
2013-05-22 |
2017-05-03 |
四川海思科制药有限公司 |
苯并呋喃衍生物、其制备方法及其在医药上的应用
|
KR101709436B1
(ko)
|
2013-06-14 |
2017-02-22 |
길리애드 사이언시즈, 인코포레이티드 |
포스파티딜이노시톨 3-키나제 억제제
|
WO2015000412A1
(zh)
|
2013-07-02 |
2015-01-08 |
四川海思科制药有限公司 |
苯并环丁烯类衍生物、其制备方法及其在医药上的应用
|
US10478445B2
(en)
|
2013-07-03 |
2019-11-19 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
US20160145304A1
(en)
|
2013-07-12 |
2016-05-26 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Cystobactamides
|
CN104341407A
(zh)
|
2013-07-24 |
2015-02-11 |
黄传满 |
喹唑啉类化合物及其制备方法和用途
|
WO2015011281A1
(en)
|
2013-07-25 |
2015-01-29 |
Janssen R&D Ireland |
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
WO2015010655A1
(zh)
|
2013-07-26 |
2015-01-29 |
四川海思科制药有限公司 |
三元并环羧酸类衍生物、其制备方法及其在医药上的应用
|
US9657023B2
(en)
|
2013-07-30 |
2017-05-23 |
Gilead Connecticut, Inc. |
Polymorph of Syk inhibitors
|
PT3031799T
(pt)
|
2013-08-09 |
2018-07-04 |
Takeda Pharmaceuticals Co |
Composto aromático
|
CN104418801B
(zh)
|
2013-08-19 |
2016-10-05 |
上海润诺生物科技有限公司 |
苯并哌啶环与苯并吗啉环类化合物、其制法及医药应用
|
US20160200734A1
(en)
*
|
2013-08-23 |
2016-07-14 |
Xinshan Kang |
Carboxylic acid compounds in treatment of diabetes mellitus
|
EP3039019B1
(en)
|
2013-08-26 |
2020-04-22 |
Purdue Pharma L.P. |
Azaspiro[4.5]decane derivatives and use thereof
|
WO2015028960A1
(en)
|
2013-08-28 |
2015-03-05 |
Piramal Enterprises Limited |
Substituted heterocyclic derivatives as gpr agonists and uses thereof
|
WO2015032328A1
(zh)
|
2013-09-03 |
2015-03-12 |
四川海思科制药有限公司 |
茚满衍生物及其制备方法和在医药上的应用
|
AU2014315457B2
(en)
|
2013-09-04 |
2018-05-10 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
PT3363790T
(pt)
|
2013-09-06 |
2020-05-06 |
Aurigene Discovery Tech Ltd |
Derivados 1,2,4-oxadiazoles como imunomoduladores
|
RS61540B1
(sr)
|
2013-09-11 |
2021-04-29 |
Inst Nat Sante Rech Med |
Postupci i farmaceutske kompozicije za tretiranje infekcije hepatitis b virusa
|
JP6533778B2
(ja)
|
2013-09-26 |
2019-06-19 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Gpr40アゴニストとしてのインダニルオキシジヒドロベンゾフラニル酢酸誘導体を調製するための方法および中間体
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
AP2016009122A0
(en)
|
2013-10-23 |
2016-03-31 |
Janssen Sciences Ireland Uc |
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
WO2015062486A1
(en)
|
2013-10-31 |
2015-05-07 |
Sunshine Lake Pharma Co., Ltd. |
Biphenyl compounds and uses thereof
|
US9115113B2
(en)
|
2013-11-14 |
2015-08-25 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
EP3068788A1
(en)
|
2013-11-14 |
2016-09-21 |
Cadila Healthcare Limited |
Novel heterocyclic compounds
|
US10519115B2
(en)
|
2013-11-15 |
2019-12-31 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
EP3071553A4
(en)
|
2013-11-21 |
2017-08-02 |
PTC Therapeutics, Inc. |
Substituted pyridine and pyrazine bmi-1 inhibitors
|
EP3610872A1
(en)
|
2013-11-27 |
2020-02-19 |
Epics Therapeutics |
Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
|
EP3074375B1
(en)
|
2013-11-28 |
2018-04-04 |
Boehringer Ingelheim International GmbH |
New indanyloxyphenylcyclopropanecarboxylic acids
|
US9957219B2
(en)
|
2013-12-04 |
2018-05-01 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
TW201609722A
(zh)
|
2013-12-13 |
2016-03-16 |
美國禮來大藥廠 |
新穎三唑并吡啶化合物
|
WO2015089809A1
(en)
|
2013-12-19 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Antidiabetic substituted heteroaryl compounds
|
US9290505B2
(en)
|
2013-12-23 |
2016-03-22 |
Gilead Sciences, Inc. |
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
|
TWI662037B
(zh)
|
2013-12-23 |
2019-06-11 |
美商基利科學股份有限公司 |
脾酪胺酸激酶抑制劑
|
CN105899509B
(zh)
|
2014-01-10 |
2018-01-02 |
伊莱利利公司 |
异丙基三唑并吡啶化合物
|
MX2016008910A
(es)
|
2014-01-10 |
2016-10-04 |
Lilly Co Eli |
Compuestos de fenil-triazolo-piridina.
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
EP3099685B1
(en)
|
2014-01-30 |
2018-04-18 |
F.Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
EP3102198B1
(en)
|
2014-02-06 |
2020-08-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic compounds
|
ES2705401T3
(es)
|
2014-02-06 |
2019-03-25 |
Janssen Sciences Ireland Uc |
Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la Hepatitis B
|
CR20160337A
(es)
|
2014-03-07 |
2016-09-20 |
Hoffmann La Roche |
Nuevas heteroarildihidropirimidinas 6-fusionadas para el tratamiento y la profilaxis de la infección por virus de la hepatitis b
|
JP2017507983A
(ja)
|
2014-03-18 |
2017-03-23 |
アイティーオス セラペウティクス |
新規な3−インドール置換誘導体、医薬組成物、および使用方法
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
JP6554117B2
(ja)
|
2014-04-04 |
2019-07-31 |
イオメット ファーマ リミテッド |
医療で使用されるインドール誘導体
|
HRP20220362T1
(hr)
|
2014-04-04 |
2022-05-13 |
Pfizer Inc. |
Biciklički kondenzirani heteroarilni ili arilni spojevi i njihova upotreba kao inhibitori irak4
|
US10865242B2
(en)
|
2014-04-10 |
2020-12-15 |
Seattle Children's Hospital |
Method and compositions for cellular immunotherapy
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
US10301260B2
(en)
|
2014-05-07 |
2019-05-28 |
Bristol-Myers Squibb Company |
Pyrrolidine GPR40 modulators
|
JP6488320B2
(ja)
|
2014-05-07 |
2019-03-20 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
糖尿病などの疾患の治療用のピロリジンgpr40モジュレータ
|
PE20161363A1
(es)
|
2014-05-07 |
2016-12-17 |
Bristol Myers Squibb Co |
Moduladores del receptor acoplado a la proteina g40 (gpr40) de pirrolidina para el tratamiento de enfermedades como la diabetes
|
WO2015173164A1
(en)
|
2014-05-13 |
2015-11-19 |
F. Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
WO2015176267A1
(en)
|
2014-05-22 |
2015-11-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
CA2951259A1
(en)
|
2014-06-06 |
2015-12-10 |
Flexus Biosciences, Inc. |
Immunoregulatory agents
|
US10471028B2
(en)
|
2014-06-13 |
2019-11-12 |
University Of Rochester |
Small molecule efflux pump inhibitors
|
GB201411239D0
(en)
|
2014-06-25 |
2014-08-06 |
Takeda Pharmaceutical |
Novel compounds
|
GB201411236D0
(en)
|
2014-06-25 |
2014-08-06 |
Takeda Pharmaceutical |
Novel compounds
|
TW201613878A
(en)
|
2014-07-09 |
2016-04-16 |
Janssen Pharmaceutica Nv |
Pyrazine GPR40 agonists for the treatment of type II diabetes
|
WO2016012470A1
(en)
|
2014-07-25 |
2016-01-28 |
F. Hoffmann-La Roche Ag |
New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
|
EP3174537B1
(en)
|
2014-07-29 |
2021-06-23 |
Merck Sharp & Dohme Corp. |
Monocyclic isoxazolines as inhibitors of cholesterol ester transfer protein
|
US10100042B2
(en)
|
2014-08-08 |
2018-10-16 |
Merck Sharp & Dohme Corp. |
[5,6]—fused bicyclic antidiabetic compounds
|
WO2016019587A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
[7, 6]-fused bicyclic antidiabetic compounds
|
US10662171B2
(en)
|
2014-08-08 |
2020-05-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
WO2016022742A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
EP3180319B1
(en)
|
2014-08-14 |
2018-10-03 |
F.Hoffmann-La Roche Ag |
Novel pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection
|
GB201414730D0
(en)
|
2014-08-19 |
2014-10-01 |
Tpp Global Dev Ltd |
Pharmaceutical compound
|
AR101692A1
(es)
|
2014-08-27 |
2017-01-04 |
Epitherapeutics Aps |
Compuestos y métodos para inhibir histonas demetilasas
|
WO2016032120A1
(ko)
|
2014-08-27 |
2016-03-03 |
씨제이헬스케어 주식회사 |
신규한 아미노-페닐-설포닐-아세테이트 유도체 및 이의 용도
|
TWI751102B
(zh)
|
2014-08-28 |
2022-01-01 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
KR102330652B1
(ko)
|
2014-09-11 |
2021-11-23 |
브리스톨-마이어스 스큅 컴퍼니 |
Pd-1/pd-l1 및 cd80 (b7-1)/pd-li 단백질/단백질 상호작용의 마크로시클릭 억제제
|
UY35733A
(es)
|
2014-09-12 |
2016-04-01 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Inhibidores macrocíclicos de las interacciones proteína/proteína pd-1/pd-l1 y cd80(b7-1)/pd-l1 i.p.c.
|
US20170283408A1
(en)
|
2014-09-19 |
2017-10-05 |
Yen-Ta Lu |
Benzo-heterocyclic compounds and their applications
|
EA201790395A1
(ru)
|
2014-09-26 |
2017-08-31 |
Джилид Сайэнс, Инк. |
Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
|
EP3204379B1
(en)
|
2014-10-10 |
2019-03-06 |
Genentech, Inc. |
Pyrrolidine amide compounds as histone demethylase inhibitors
|
WO2016060963A1
(en)
|
2014-10-14 |
2016-04-21 |
Sunshine Lake Pharma Co., Ltd. |
Substituted heteroaryl compounds and methods of use
|
DK3207928T3
(da)
|
2014-10-17 |
2021-04-26 |
Hyundai Pharm Co Ltd |
Sammensat præparat, der indeholder hidtil ukendt 3-(4-(benzyloxy)phenyl)hex-4-inonsyrederivat og en anden aktiv bestanddel, til forebyggelse eller behandling af metaboliske sygdomme
|
SG10201903578VA
(en)
|
2014-10-24 |
2019-05-30 |
Bristol Myers Squibb Co |
Indole carboxamides compounds useful as kinase inhibitors
|
KR101857146B1
(ko)
|
2014-10-28 |
2018-05-11 |
삼성에스디아이 주식회사 |
유기 광전자 소자 및 표시 장치
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
CA2965741C
(en)
|
2014-11-03 |
2022-05-17 |
Iomet Pharma Ltd |
Pharmaceutical compound
|
GB201419579D0
(en)
|
2014-11-03 |
2014-12-17 |
Iomet Pharma Ltd |
Pharmaceutical compound
|
UY36390A
(es)
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
|
UY36391A
(es)
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
|
US9856292B2
(en)
|
2014-11-14 |
2018-01-02 |
Bristol-Myers Squibb Company |
Immunomodulators
|
MX2017007138A
(es)
|
2014-12-03 |
2017-08-28 |
Juno Therapeutics Inc |
Metodos y composiciones para terapia celular adoptiva.
|
CN107206088A
(zh)
|
2014-12-05 |
2017-09-26 |
豪夫迈·罗氏有限公司 |
使用pd‑1轴拮抗剂和hpk1拮抗剂用于治疗癌症的方法和组合物
|
WO2016100236A2
(en)
|
2014-12-15 |
2016-06-23 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlled elimination of therapeutic cells
|
WO2016102438A1
(en)
|
2014-12-23 |
2016-06-30 |
F. Hoffmann-La Roche Ag |
Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidine analogues
|
US9676793B2
(en)
|
2014-12-23 |
2017-06-13 |
Hoffmann-Laroche Inc. |
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
|
CN107108610B
(zh)
|
2014-12-30 |
2019-06-04 |
豪夫迈·罗氏有限公司 |
用于治疗和预防肝炎b病毒感染的新的四氢吡啶并嘧啶和四氢吡啶并吡啶化合物
|
EP3240913A1
(en)
|
2014-12-31 |
2017-11-08 |
F. Hoffmann-La Roche AG |
A novel high-throughput method for quantification of hbv cccdna from cell lysate by real-time pcr
|
WO2016110821A1
(en)
|
2015-01-08 |
2016-07-14 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
CN107208102B
(zh)
|
2015-01-27 |
2021-07-06 |
豪夫迈·罗氏有限公司 |
重组hbv cccdna、其产生方法及其用途
|
US20160222060A1
(en)
|
2015-02-04 |
2016-08-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
CA2981753A1
(en)
|
2015-02-06 |
2016-08-11 |
Unity Biotechnology, Inc. |
Compounds and uses in treatment of senescence-associated conditions
|
CN107207505B
(zh)
|
2015-02-11 |
2018-12-14 |
豪夫迈·罗氏有限公司 |
治疗和预防乙型肝炎病毒感染的 2-氧代-6,7-二氢苯并[a]喹嗪-3-甲酸衍生物
|
WO2016128908A1
(en)
|
2015-02-12 |
2016-08-18 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
CN107427491A
(zh)
|
2015-03-10 |
2017-12-01 |
奥瑞基尼探索技术有限公司 |
作为免疫调节剂的治疗性环状化合物
|
CA2979161A1
(en)
|
2015-03-10 |
2016-09-15 |
Aurigene Discovery Technologies Limited |
3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
|
ES2907988T3
(es)
|
2015-03-10 |
2022-04-27 |
Aurigene Discovery Tech Ltd |
Compuestos de 1,2,4-oxadiazol y tiadiazol como inmunomoduladores
|
CN107427497A
(zh)
|
2015-03-10 |
2017-12-01 |
奥瑞基尼探索技术有限公司 |
作为免疫调节剂的3‑取代的1,3,4‑噁二唑和噻二唑化合物
|
EA201791629A1
(ru)
|
2015-03-10 |
2018-02-28 |
Ауриджен Дискавери Текнолоджис Лимитед |
1,3,4-оксадиазольные и тиадиазольные соединения в качестве иммуномодуляторов
|
CN104876912B
(zh)
|
2015-04-08 |
2017-07-21 |
苏州云轩医药科技有限公司 |
Wnt信号通路抑制剂及其应用
|
CA2985642A1
(en)
|
2015-05-15 |
2016-11-24 |
Gilead Sciences, Inc. |
Benzimidazole and imadazopyridine carboximidamide compounds having activity as inhibitors of indoleamine 2,3-dioxygenase
|
US20180161368A1
(en)
|
2015-05-29 |
2018-06-14 |
Juno Therapeutics, Inc. |
Composition and methods for regulating inhibitory interactions in genetically engineered cells
|
AR104020A1
(es)
|
2015-06-04 |
2017-06-21 |
Kura Oncology Inc |
Métodos y composiciones para inhibir la interacción de menina con proteínas mill
|
WO2016197987A1
(zh)
|
2015-06-12 |
2016-12-15 |
杭州英创医药科技有限公司 |
作为Syk抑制剂和/或Syk-HDAC双重抑制剂的杂环化合物
|
US20180230166A1
(en)
|
2015-07-13 |
2018-08-16 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocycles as inhibitors of cholesterol ester transfer protein
|
US9617251B2
(en)
|
2015-08-07 |
2017-04-11 |
Boehringer Ingelheim International Gmbh |
Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
WO2017027312A1
(en)
|
2015-08-12 |
2017-02-16 |
Janssen Pharmaceutica Nv |
Gpr40 agonists for the treatment of type ii diabetes
|
US9908873B2
(en)
|
2015-08-12 |
2018-03-06 |
Janssen Pharmaceutica Nv |
GPR40 agonists for the treatment of type II diabetes
|
WO2017027309A1
(en)
|
2015-08-12 |
2017-02-16 |
Janssen Pharmaceutica Nv |
Gpr40 agonists for the treatment of type ii diabetes
|
WO2017031392A1
(en)
|
2015-08-20 |
2017-02-23 |
University Of Florida Research Foundation, Incorporated |
Lipid compounds for treatment of obesity, hypertension and metabolic syndrome
|
US20180354962A1
(en)
|
2015-09-09 |
2018-12-13 |
Boehringer Ingelheim International Gmbh |
[{[2,3-Dihydro-1H-inden-1-yl]amino}-2H,3H-furo[3,2-b]pyridin-3-yl]acetic acids, pharmaceutical compositions and uses thereof
|
BR112018005295A2
(pt)
|
2015-09-17 |
2018-12-11 |
Novartis Ag |
terapias com célula t car com eficácia aumentada
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
ES2928164T3
(es)
|
2015-10-19 |
2022-11-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
MX2018005600A
(es)
|
2015-11-04 |
2018-11-09 |
Incyte Corp |
Composiciones farmaceuticas y metodos para la inhibicion de indolamina 2,3-dioxigenasa e indicaciones para ello.
|
MX2018006207A
(es)
|
2015-11-19 |
2018-09-05 |
Incyte Corp |
Compuestos heterociclicos como inmunomoduladores.
|
US20180362650A1
(en)
|
2015-12-07 |
2018-12-20 |
Kyoto University |
Pd-1 signal inhibitor combination therapy
|
ES2916874T3
(es)
|
2015-12-17 |
2022-07-06 |
Incyte Corp |
Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1
|
EA201891494A1
(ru)
|
2015-12-22 |
2019-01-31 |
Инсайт Корпорейшн |
Гетероциклические соединения в качестве иммуномодуляторов
|
WO2017107979A1
(en)
|
2015-12-24 |
2017-06-29 |
Genentech, Inc. |
Tdo2 inhibitors
|
EP3190103A1
(en)
|
2016-01-08 |
2017-07-12 |
Rijksuniversiteit Groningen |
Inhibitors of the pd-1/pd-l1 protein/protein interaction
|
WO2017143220A1
(en)
|
2016-02-17 |
2017-08-24 |
Children's Medical Center Corporation |
Ffa1 (gpr40) as a therapeutic target for neural angiogenesis diseases or disorders
|
US10143746B2
(en)
|
2016-03-04 |
2018-12-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US9798514B2
(en)
|
2016-03-09 |
2017-10-24 |
Spotify Ab |
System and method for color beat display in a media content environment
|
US20190127314A1
(en)
|
2016-03-23 |
2019-05-02 |
Symrise Ag |
Homovanillic acid ester for reducing or inhibiting fatty acid absorption in the small intestine
|
EP3436003B1
(en)
|
2016-03-29 |
2023-08-23 |
Merck Sharp & Dohme LLC |
Antidiabetic bicyclic compounds
|
US10358463B2
(en)
|
2016-04-05 |
2019-07-23 |
Bristol-Myers Squibb Company |
Immunomodulators
|
WO2017180457A1
(en)
|
2016-04-11 |
2017-10-19 |
Janssen Pharmaceutica Nv |
Gpr40 agonists in anti-diabetic drug combinations
|
WO2017180571A1
(en)
|
2016-04-11 |
2017-10-19 |
Janssen Pharmaceutica Nv |
Substituted benzothiophenyl derivatives as gpr40 agonists for the treatment of type ii diabetes
|
WO2017180769A1
(en)
|
2016-04-13 |
2017-10-19 |
Capten Therapeutics Inc. |
Small molecules for immunogenic treatment of cancer
|
EP3452476B1
(en)
|
2016-05-06 |
2021-12-15 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
JP6905053B2
(ja)
|
2016-05-23 |
2021-07-21 |
中国医学科学院薬物研究所Institute Of Materia Medica, Chinese Academy Of Medical Sciences |
ベンジルフェニルエーテル誘導体、その調製方法、並びにその医薬組成物及び使用
|
WO2017201683A1
(en)
|
2016-05-25 |
2017-11-30 |
Merck Sharp & Dohme Corp. |
Substituted tetrahydroisoquinoline compounds useful as gpr120 agonists
|
SG11201810423XA
(en)
|
2016-05-26 |
2018-12-28 |
Merck Patent Gmbh |
Pd-1 / pd-l1 inhibitors for cancer treatment
|
ES2905980T3
(es)
|
2016-05-26 |
2022-04-12 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
HUE060256T2
(hu)
|
2016-06-20 |
2023-02-28 |
Incyte Corp |
Heterociklusos vegyületek mint immunmodulátorok
|
CN109803651B
(zh)
|
2016-06-27 |
2022-05-31 |
凯莫森特里克斯股份有限公司 |
免疫调节剂化合物
|
ES2895066T3
(es)
|
2016-07-08 |
2022-02-17 |
Bristol Myers Squibb Co |
Derivados de 1,3-dihidroxi-fenilo útiles como inmunomoduladores
|
CN109195602B
(zh)
*
|
2016-08-03 |
2022-01-07 |
上海齐鲁制药研究中心有限公司 |
用作免疫调节剂的对称或半对称化合物
|
EP3281937A1
(en)
|
2016-08-09 |
2018-02-14 |
Dompé farmaceutici S.p.A. |
Sulfonamides as gpr40- and gpr120-agonists
|
US10563620B2
(en)
|
2016-08-12 |
2020-02-18 |
Rolls-Royce North American Technologies Inc. |
Expandable exhaust cone
|
WO2018044783A1
(en)
|
2016-08-29 |
2018-03-08 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US10144706B2
(en)
|
2016-09-01 |
2018-12-04 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
US10734026B2
(en)
|
2016-09-01 |
2020-08-04 |
Facebook, Inc. |
Systems and methods for dynamically providing video content based on declarative instructions
|
TW201823199A
(zh)
|
2016-09-02 |
2018-07-01 |
美商北極星藥品公司 |
免疫檢查點抑制劑、組成物及其方法
|
WO2018051254A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators
|
WO2018051255A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators
|
WO2018053302A1
(en)
|
2016-09-19 |
2018-03-22 |
Ensemble Therapeutics Corporation |
Macrocyclic compounds for the inhibition of indoleamine-2,3-dioxygenase activity and use thereof
|
WO2018081047A1
(en)
|
2016-10-25 |
2018-05-03 |
Janssen Pharmaceutica Nv |
Cyclohexyl gpr40 agonists for the treatment of type ii diabetes
|
US10538490B2
(en)
|
2016-10-25 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
WO2018095877A1
(en)
|
2016-11-28 |
2018-05-31 |
Boehringer Ingelheim International Gmbh |
Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
EP3551176A4
(en)
|
2016-12-06 |
2020-06-24 |
Merck Sharp & Dohme Corp. |
ANTIDIABETIC HETEROCYCLIC COMPOUNDS
|
KR102007633B1
(ko)
|
2016-12-15 |
2019-08-06 |
일동제약(주) |
신규 페닐 프로피온 산 유도체 및 이의 용도
|
EP3558298A4
(en)
|
2016-12-20 |
2020-08-05 |
Merck Sharp & Dohme Corp. |
ANTIDIABETIC SPIROCHROMAN COMPOUNDS
|
CA3047394A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Combinations of pd-1 antagonists and cyclic dinucleotide sting agonists for cancer treatment
|
JP7106572B2
(ja)
|
2016-12-20 |
2022-07-26 |
ブリストル-マイヤーズ スクイブ カンパニー |
免疫調節剤として有用な化合物
|
EP3558973B1
(en)
|
2016-12-22 |
2021-09-15 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
HRP20221216T1
(hr)
|
2016-12-22 |
2022-12-23 |
Incyte Corporation |
Derivati tetrahidro imidazo[4,5-c]piridina kao induktori internalizacije pd-l1
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
KR20190111025A
(ko)
|
2016-12-22 |
2019-10-01 |
인사이트 코포레이션 |
면역조절제로서의 벤조옥사졸 유도체
|
US20180179202A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
US10654815B2
(en)
|
2016-12-29 |
2020-05-19 |
Shenzhen Chipscreen Biosciences Co., Ltd. |
Urea compound and preparation method and application thereof
|
US10919859B2
(en)
|
2017-01-26 |
2021-02-16 |
Boehringer Ingelheim International Gmbh |
Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
WO2018138029A1
(en)
|
2017-01-26 |
2018-08-02 |
Boehringer Ingelheim International Gmbh |
Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
US10603317B2
(en)
|
2017-01-26 |
2020-03-31 |
Boehringer Ingelheim International Gmbh |
Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
WO2018138028A1
(en)
|
2017-01-26 |
2018-08-02 |
Boehringer Ingelheim International Gmbh |
Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
EP3573965B1
(en)
|
2017-01-26 |
2021-06-23 |
Boehringer Ingelheim International GmbH |
Indanylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
US10550127B1
(en)
|
2017-02-08 |
2020-02-04 |
Boehringer Ingelheim International Gmbh |
Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes
|
CN110402248B
(zh)
|
2017-03-15 |
2023-01-06 |
豪夫迈·罗氏有限公司 |
作为hpk1抑制剂的氮杂吲哚类
|
GB201704714D0
(en)
|
2017-03-24 |
2017-05-10 |
Caldan Therapeutics Ltd |
Pharmaceutical compounds
|
WO2018183171A1
(en)
|
2017-03-27 |
2018-10-04 |
Bristol-Myers Squibb Company |
Substituted isoquionline derivatives as immunomudulators
|
CR20190424A
(es)
|
2017-03-30 |
2019-11-04 |
Hoffmann La Roche |
Isoquinolinas como inhibidores de hpk1
|
TW201904964A
(zh)
|
2017-03-30 |
2019-02-01 |
瑞士商赫孚孟拉羅股份公司 |
作為hpk1之抑制劑的啶
|
AR111199A1
(es)
|
2017-03-31 |
2019-06-12 |
Takeda Pharmaceuticals Co |
Compuesto aromático agonista de gpr40
|
US11186565B2
(en)
|
2017-03-31 |
2021-11-30 |
Takeda Pharmaceutical Company Limited |
Aromatic compound
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
WO2018196768A1
(zh)
|
2017-04-26 |
2018-11-01 |
南京圣和药业股份有限公司 |
作为pd-l1抑制剂的杂环类化合物
|
WO2019008156A1
(en)
|
2017-07-07 |
2019-01-10 |
Rijksuniversiteit Groningen |
INHIBITORS OF PROTEIN / PROTEIN INTERACTION PD-1 / PD-L1
|
CA3070794A1
(en)
|
2017-07-28 |
2019-01-31 |
Chemocentryx, Inc. |
Immunomodulator compounds
|
CA3071951A1
(en)
|
2017-08-08 |
2019-02-14 |
Chemocentryx, Inc. |
Macrocyclic immunomodulators
|
WO2019034172A1
(zh)
|
2017-08-18 |
2019-02-21 |
上海轶诺药业有限公司 |
一种具有pd-l1抑制活性的化合物、其制备方法及用途
|
JP7382922B2
(ja)
|
2017-09-20 |
2023-11-17 |
中外製薬株式会社 |
Pd-1系結合アンタゴニストおよびgpc3標的化剤を使用する併用療法のための投与レジメン
|
JP7257393B2
(ja)
|
2017-10-03 |
2023-04-13 |
ブリストル-マイヤーズ スクイブ カンパニー |
免疫調節剤
|
WO2019074241A1
(ko)
|
2017-10-11 |
2019-04-18 |
정원혁 |
페닐아세틸렌 유도체를 포함하는 pd-1과 pd-l1의 상호작용 억제제
|
CN109678796B
(zh)
|
2017-10-19 |
2023-01-10 |
上海长森药业有限公司 |
Pd-1/pd-l1小分子抑制剂及其制备方法和用途
|
AU2018398887B2
(en)
|
2017-12-29 |
2024-03-14 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd |
Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
|
PL3752501T3
(pl)
*
|
2018-02-13 |
2023-08-21 |
Gilead Sciences, Inc. |
Inhibitory pd-1/pd-l1
|
WO2019165043A2
(en)
|
2018-02-22 |
2019-08-29 |
Chemocentryx, Inc. |
Indane-amines as pd-l1 antagonists
|
BR102019004480B1
(pt)
|
2018-03-08 |
2023-03-28 |
Dow Agrosciences Llc |
Picolinamidas como fungicidas
|
GB201803736D0
(en)
|
2018-03-08 |
2018-04-25 |
Syngenta Participations Ag |
Improvements in or relating to organic compounds
|
MX2020009228A
(es)
|
2018-03-08 |
2021-01-08 |
Incyte Corp |
Compuestos diolicos de aminopirazina como inhibidores de fosfoinositida 3-cinasas-gamma.
|
CN112105610B
(zh)
|
2018-03-13 |
2024-01-26 |
朱比连特普罗德尔有限责任公司 |
作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物
|
WO2019174533A1
(zh)
|
2018-03-13 |
2019-09-19 |
广东东阳光药业有限公司 |
Pd-1/pd-l1类小分子抑制剂及其在药物中的应用
|
WO2019191624A1
(en)
|
2018-03-29 |
2019-10-03 |
Arbutus Biopharma, Inc. |
Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same
|
HRP20230090T1
(hr)
|
2018-03-30 |
2023-03-17 |
Incyte Corporation |
Heterociklički spojevi kao imunomodulatori
|
US20210040118A1
(en)
|
2018-04-03 |
2021-02-11 |
Betta Pharmaceuticals Co., Ltd |
Immunomodulators, compositions and methods thereof
|
US10899735B2
(en)
|
2018-04-19 |
2021-01-26 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
SG11202011165TA
(en)
|
2018-05-11 |
2020-12-30 |
Incyte Corp |
Tetrahydro-imidazo[4,5-c]pyridine derivatives as pd-l1 immunomodulators
|
JP7105359B2
(ja)
|
2018-07-13 |
2022-07-22 |
ギリアード サイエンシーズ, インコーポレイテッド |
Pd-1/pd-l1阻害剤
|
WO2020011246A1
(zh)
|
2018-07-13 |
2020-01-16 |
广州丹康医药生物有限公司 |
含苯环的化合物、其制备方法及应用
|
AU2019366355B2
(en)
|
2018-10-24 |
2022-10-13 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|